XORTX Therapeutics Stock (NASDAQ: XRTX) stock price, news, charts, stock research, profile.
Open | $2.750 |
Close | - |
Volume / Avg. | 21.893K / 49.491K |
Day Range | 2.530 - 2.765 |
52 Wk Range | 1.980 - 609.444 |
Market Cap | $8.058M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 0.74% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of XORTX Therapeutics (NASDAQ: XRTX) through any online brokerage.
There are no as such competitors for XORTX Therapeutics.
The latest price target for XORTX Therapeutics (NASDAQ: XRTX) was reported by Alliance Global Partners on Thursday, January 4, 2024. The analyst firm set a price target for 14.00 expecting XRTX to rise to within 12 months (a possible 403.60% upside). 1 analyst firms have reported ratings in the last year.
The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $2.78 last updated Today at April 26, 2024 at 3:01 PM EDT.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on February 17, 2014 to stockholders of record on January 31, 2014.
XORTX Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for XORTX Therapeutics.
XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.